In vivo proof of concept for TOP-N53, a highly potent topical drug for acceleration of wound healing - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

18271.2 PFLS-LS

Project title

In vivo proof of concept for TOP-N53, a highly potent topical drug for acceleration of wound healing

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	In vivo proof of concept (PoC) für TOP-N53, ein hochwirksamer topischer Wirkstoff für beschleunigte Wundheilung
Short description (English)	In vivo proof of concept for TOP-N53, a highly potent topical drug for acceleration of wound healing
Abstract (German)	The project goals are the Proof-of-Mechanism (PoM) and Proof-of-Concept (PoC) in animal wound healing models for TOP-N53. TOP-N53 is a highly potent, unique dual-mode of action drug currently in preclinical development at Topadur Pharma AG to accelerate healing of chronic, non-healing cutaneous wounds such as diabetic foot ulcers.
Abstract (English)	The project goals are the Proof-of-Mechanism (PoM) and Proof-of-Concept (PoC) in animal wound healing models for TOP-N53. TOP-N53 is a highly potent, unique dual-mode of action drug currently in preclinical development at Topadur Pharma AG to accelerate healing of chronic, non-healing cutaneous wounds such as diabetic foot ulcers.